Sarcopenia and Visceral Metastasis at Cabazitaxel Initiation Predict Prognosis in Patients With Castration-resistant Prostate Cancer Receiving Cabazitaxel Chemotherapy

Background/Aim: Cabazitaxel is recommended as first-line treatment after docetaxel for metastatic castration-resistant prostate cancer. However, the efficacy, adverse events and prognostic factors associated with cabazitaxel are unclear. Patients and Methods: This single-centre retrospective study i...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:In Vivo
Päätekijät: IWAMOTO, HIROAKI, KANO, HIROSHI, SHIMADA, TAKAFUMI, NAITO, RENATO, MAKINO, TOMOYUKI, KADOMOTO, SUGURU, YAEGASHI, HIROSHI, SHIGEHARA, KAZUYOSHI, IZUMI, KOUJI, KADONO ATSUSHI MIZOKAMI, YOSHIFUMI
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: International Institute of Anticancer Research 2021
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8193302/
https://ncbi.nlm.nih.gov/pubmed/33910855
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12430
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia